---
figid: PMC4772904__nihms-762306-f0001
figtitle: NSAIDs inhibit PGE2-induced tumorigenesis through targeting multiple downstream
  signaling pathways of PGE2
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Drosophila melanogaster
pmcid: PMC4772904
filename: nihms-762306-f0001.jpg
figlink: /pmc/articles/PMC4772904/figure/F1/
number: F1
caption: NSAIDs inhibit PGE2-induced tumorigenesis through targeting multiple downstream
  signaling pathways of PGE2. PGE2 exerts its biological activity by binding to EP
  receptors EP1, EP2, EP3, and EP4. The EP receptor signaling pathways control cell
  proliferation, invasion, apoptosis, and angiogenesis. The EP2/4 receptors are G
  protein-coupled receptors. PGE2 can activate the PKA signaling pathway mediating
  many of pro-tumorigenic activities. The PKA pathway phosphorylates GSK-3, thereby
  altering the APC/β-catenin/TCF pathway, which regulates cell proliferation, angiogenesis,
  and apoptosis. PGE2 can also transactivate the EGF receptor and activate MAP kinase
  ERK1/2 pathway that induce proliferation and/or PI3K-ATK signaling pathway and thus
  transactivate the PPARδ cascade and induce transcriptional regulation of genes promoting
  cell survival, invasion and angiogenesis
papertitle: 'COX inhibitors directly alter gene expression: role in cancer prevention?.'
reftext: Xingya Wang, et al. Cancer Metastasis Rev. ;30(0):641-657.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9553487
figid_alias: PMC4772904__F1
figtype: Figure
redirect_from: /figures/PMC4772904__F1
ndex: d7e60160-deea-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4772904__nihms-762306-f0001.html
  '@type': Dataset
  description: NSAIDs inhibit PGE2-induced tumorigenesis through targeting multiple
    downstream signaling pathways of PGE2. PGE2 exerts its biological activity by
    binding to EP receptors EP1, EP2, EP3, and EP4. The EP receptor signaling pathways
    control cell proliferation, invasion, apoptosis, and angiogenesis. The EP2/4 receptors
    are G protein-coupled receptors. PGE2 can activate the PKA signaling pathway mediating
    many of pro-tumorigenic activities. The PKA pathway phosphorylates GSK-3, thereby
    altering the APC/β-catenin/TCF pathway, which regulates cell proliferation, angiogenesis,
    and apoptosis. PGE2 can also transactivate the EGF receptor and activate MAP kinase
    ERK1/2 pathway that induce proliferation and/or PI3K-ATK signaling pathway and
    thus transactivate the PPARδ cascade and induce transcriptional regulation of
    genes promoting cell survival, invasion and angiogenesis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLA2G1B
  - PLA2G2A
  - PLA2G6
  - PLA2G3
  - PLA2G5
  - PLA2G7
  - PLA2G10
  - PLA2G12A
  - PLA2G12B
  - PLA2G2C
  - PLA2G2D
  - PLA2G2E
  - PLA2G2F
  - PLA2G4A
  - PLA2G4C
  - PLA2G4D
  - PTGS2
  - COX1
  - PTGS1
  - CTNNB1
  - RXRA
  - RXRB
  - RXRG
  - PTGES
  - GSK3B
  - AKT1
  - AKT2
  - AKT3
  - HNF4A
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK3
  - MAPK1
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - PTGER4
  - PTGER2
  - SPAG11B
  - EGFR
  - Ptgs2
  - Ptgs1
  - Ctnnb1
  - Gsk3b
  - Akt1
  - Pik3cg
  - Mapk3
  - Mapk1
  - Ptger4
  - Ptger2
  - Egfr
  - Pla2g2a
  - Pla2g5
  - Ptges
  - Pik3r1
  - CG42237
  - COX2
  - arm
  - sgg
  - gskt
  - Akt
  - pan
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - rl
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Arachidonic acid
  - PGE
---
